Page 272 - HIVMED_v21_i1.indb

Page 8 of 8 Original Research

Disclaimer 8. Council of Medical Schemes, South Africa. Annual report 2017/18 [homepage
on the Internet]. c2017 [cited 2020 Jan 28]. Available from: http://www.
The views and opinions expressed in this article are those of medicalschemes.com/Publications.aspx
the authors and do not necessarily reflect the official policy or 9. Council for Medical Schemes, South Africa. Annual report 2015/2016 [homepage
on the Internet]. c2016 [cited 2019 May 10]. Available from: http://www.
position of any affiliated agency of the authors. medicalschemes.com/Publications.aspx
10. World Health Organization. International statistical classification of diseases and
related health problems [homepage on the Internet]. 10th revised ed. c2011
References [cited 2019 Jun 25]. Available from: https://www.who.int/classifications/icd/
ICD10Volume2_en_2010.pdf
11. Centre for Disease Control and Prevention. Lesson 3: Measure risk. Section 1:
1. GBD 2017 HIV Collaborators. Global, regional, and national incidence, prevalence, Frequency measures. In: Principle of epidemiology in public health practice. 3rd
and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and ed. An introduction to applied epidemiology and biostatistics [homepage on
territories: A systematic analysis for the Global Burden of Diseases, injuries, and the Internet]. c2018 [cited 2019 May 10]. Available from: https://www.cdc.gov/
risk factors 2017 study. Lancet HIV. 2019;16(12):e831–e859. https://doi. ophss/csels/dsepd/ss1978/lesson3/section1.html
org/10.1016/S2352-3018(19)30196-1 12. McManus H, Hoy JF, Woolley I, et al. Recent trends in early-stage response to
2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis combination antiretroviral therapy in Australia. Antivir Ther. 2015;20(2):131–139.
incidence and mortality, 1990–2017: Analysis for the global burden of disease https://doi.org/10.3851/IMP2774
study. Lancet. 2020;395(10219):200–211. https://doi.org/10.1016/S0140-6736
(19)32989-7 13. Williams I, Churchill D, Anderson J, et al. British HIV Association (BHIVA) guidelines
for the treatment of HIV-1-positive adults with antiretroviral therapy. HIV Med.
3. Department of Health. HIV & AIDS and STI national strategic plan for South Africa 2012;13(2):1–85. https://doi.org/10.1111/j.1468-1293.2012.01029.x
2017–2022 [homepage on the Internet]. Pretoria: Department of Health; c2007
[cited 2020 Jan 29]. Available from: https://sanac.org.za//wp-content/uploads/ 14. Council of Medical Schemes, South Africa. Annual report 2016/17 [homepage
2017/06/NSP_FullDocument_FINAL.pdf on the Internet]. c2017 [cited 2019 May 10]. Available from: http://www.
medicalschemes.com/Publications.aspx
4. Council of Medical Schemes, South Africa. Medical Schemes Act 131 of 1998:
Regulations. (Government notice No. R.1397, 2003) [homepage on the Internet]. 15. Lessells RJ, Mutevedzi, PC. Iwuji C, Newell M.L. Reduction in early mortality on
Government Gazette, 25537; 2003 [cited 2019 May 10]. Available from: http:// antiretroviral therapy for adults in rural South Africa since the change in CD4+ cell
www.medicalchemes.com/publicationsZipPublicalions/Acts%20and%20 count eligibility criteria. J Acquir Immune Defic Syndr. 2014;65(1):e17–e24.
Regulations/MSREGS19July2004.pdf https://doi.org/10.1097/QAI.0b013e31829ceb14
16. Tanser F, Barnighausen T, Graspar E, et al. High coverage of ART associated with a
5. Da Silva R, Wayburne L. Effects of HIV/AIDS on medical schemes in South Africa:
Population covered. SA Actuarial J. 2008;8(1):35–91. https://doi.org/10.4314/ decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science.
saaj.v8i1.24513 2013;339(6122):966–971. https://doi.org/10.1126/science.1228160
6. Stevens M, Sinanovic E, Regensberg L, et al. HIV and AIDS: STI and TB in the private 17. Maggi P, Biagio A, Rusconi S, et al. Cardiovascular risk and dyslipidemia among
persons living with HIV. A review. BMC Infect Dis. 2017;17(1):551. https://doi.org/
sector. In: Harrison S, Bhana R, Ntuli A, editors, South African health review 2007 10.1186/s12879-017-2626-z
[homepage on the Internet]. Durban: Health Systems Trust; c2007 [cited 2020 Jan
29]. Available from: http://www.hst.org.za/publications/711 18. Duncan AD, Groff LM, Peters BS. Type 2 diabetes prevalence and its risk factors in
7. Council of Medical Schemes, Research and Monitoring Unit of the Council for HIV: A cross-sectional study. PLoS One. 2018;13(3):e0194199. https://doi.org/
10.1371/journal.pone.0194199
Medical Schemes, South Africa. Prevalence of chronic diseases in the population
covered by medical aid schemes in South Africa [homepage on the Internet]. 19. Goodkin K, Miller EN, Cox C, et al. Effect of aging in neurocognitive function by
c2019 [cited 2020 Jan 28]. Available from: http://www.medicalschemes.com/ stage of HIV infection: Evidence from the Multi-Center AIDS Cohort Study. Lancet
Publications.aspx HIV. 2017;4(9):e411–e422. https://doi.org/10.1016/52352-3018(17)30098-X

http://www.sajhivmed.org.za 264 Open Access